BioCentury
ARTICLE | Clinical News

Generx cardionovo alferminogene tadenovec: Phase III started

March 26, 2012 7:00 AM UTC

Cardium began the open-label, Russian Phase III ASPIRE trial to evaluate Generx administered through a standard cardiac infusion catheter in about 100 patients with myocardial ischemia due to coronary...